GTF2H2C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.821500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.856800E-01
Normal-vs-Stage2
2.546300E-02
Normal-vs-Stage3
3.679100E-03
Normal-vs-Stage4
2.358200E-02
Stage1-vs-Stage2
2.835600E-01
Stage1-vs-Stage3
5.716200E-02
Stage1-vs-Stage4
2.947800E-01
Stage2-vs-Stage3
6.692200E-02
Stage2-vs-Stage4
5.992400E-01
Stage3-vs-Stage4
1.284420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.481600E-02
Normal-vs-AfricanAmerican
3.604600E-01
Normal-vs-Asian
2.562000E-02
Caucasian-vs-AfricanAmerican
8.329800E-01
Caucasian-vs-Asian
2.729200E-01
AfricanAmerican-vs-Asian
4.752400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.619900E-02
Normal-vs-Female
1.621690E-02
Male-vs-Female
9.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.410000E-01
Normal-vs-Age(41-60Yrs)
1.056040E-01
Normal-vs-Age(61-80Yrs)
7.538600E-03
Normal-vs-Age(81-100Yrs)
1.455750E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.473600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.699800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.118800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.746950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.898600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.958200E-02
Normal-vs-Daily Drinker
3.840000E-02
Normal-vs-Weekly Drinker
1.218560E-01
Normal-vs-Occasional Drinker
5.409700E-02
Normal-vs-Social Drinker
5.133900E-02
Non Drinker-vs-Daily Drinker
6.623200E-01
Non Drinker-vs-Weekly Drinker
9.737200E-01
Non Drinker-vs-Occasional Drinker
8.547800E-01
Non Drinker-vs-Social Drinker
2.209800E-01
Daily Drinker-vs-Weekly Drinker
7.389400E-01
Daily Drinker-vs-Occasional Drinker
8.132800E-01
Daily Drinker-vs-Social Drinker
1.123630E-01
Weekly Drinker-vs-Occasional Drinker
9.014000E-01
Weekly Drinker-vs-Social Drinker
3.423400E-01
Occasional Drinker-vs-Social Drinker
1.903820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.400560E-01
Normal-vs-Grade 2
6.620300E-02
Normal-vs-Grade 3
4.448200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.513600E-01
Grade 1-vs-Grade 3
6.819400E-01
Grade 1-vs-Grade 4
1.400560E-01
Grade 2-vs-Grade 3
6.123800E-01
Grade 2-vs-Grade 4
6.620300E-02
Grade 3-vs-Grade 4
4.448200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.882040E-02
Normal-vs-NonDiabetic
3.193600E-02
Diabetic-vs-NonDiabetic
4.632000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.440100E-02
Normal-vs-NoPancreatitis
2.575600E-02
Pancreatitis-vs-NoPancreatitis
5.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.556400E-02
Normal-vs-N1
3.254100E-02
N0-vs-N1
6.758000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.204790E-01
Normal-vs-TP53-NonMutant
1.336400E-01
TP53-Mutant-vs-TP53-NonMutant
9.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
